Results 171 to 180 of about 10,441,214 (290)
Biosecurity Primitive: Polymerase X‐based Genetic Physical Unclonable Functions
What if every cell line can carry an unforgeable genomic fingerprint—one that proves its origin, ensures its authenticity, and thwarts unauthorized duplication? Here, CRISPR‐induced DNA lesions paired with TdT‐mediated repair produce robust, unique, and unclonable genetic signatures—advancing the concept of molecular Physical Unclonable Functions (PUF)
Zikun Zhou+7 more
wiley +1 more source
IDENTIFICATION OF A BACTERIAL GROWTH INHIBITOR FROM HELA CELLS: A KETOALDEHYDE [PDF]
Brian G. Sparkes, C. P. Kenny
openalex +1 more source
From Code to Life: The AI‐Driven Revolution in Genome Editing
This review explores AI‐driven advancements in genome editing, focusing on CRISPR optimization, enhanced targeting precision, reduced off‐target effects, and novel tool design. It addresses ethical challenges, data biases, and highlights future prospects in precision medicine, agriculture, and synthetic biology.
Zhidong Li+10 more
wiley +1 more source
T. Puck, P. I. Marcus
semanticscholar +1 more source
RIBONUCLEIC ACID AND PROTEIN SYNTHESIS IN MITOTIC HELA CELLS [PDF]
Terry C. Johnson, John J. Holland
openalex +1 more source
Small RNA Toxin‐Assisted Evolution of GC‐Preferred ErCas12a for Enhanced Genome Targeting Range
ErCas12a is engineered to target GC‐rich PAMs using a small RNA toxin‐aided positive screening system. The resulting variant, enErCas12a, exhibits an expanded PAM profile and facilitates efficient gene editing in both bacterial and mammalian cells, while preserving high targeting specificity for both canonical and non‐canonical PAM targets.
Zehua Chen+8 more
wiley +1 more source
This study identifies MTCH2 as a crucial regulator of ferroptosis in colorectal cancer (CRC) progression. High expression of MTCH2 is correlated with poor prognosis in CRC patients. Furthermore, MTCH2 depletion induces ferroptosis to suppress CRC liver metastasis via the E2F4/TFRC axis and sensitizes tumors to sorafenib treatment, supporting MTCH2 as a
Pu Xing+18 more
wiley +1 more source
The loss of rapidly labelled ribonucleic acid from isolated HeLa cell nuclei [PDF]
J. W. Watts
openalex +1 more source
Nrf2 isn't just a protector—it's a driver of cancer stemness. The study uncovers how arsenic‐activated Nrf2 directly upregulates KLF4, a key pluripotency factor, fueling oncogenic reprogramming. Through enhancer activation and self‐reinforcing loop, Nrf2 and KLF4 co‐opt gene networks linked to epithelial‐to‐mesenchymal transition and tumor growth ...
Ziwei Wang+9 more
wiley +1 more source